<DOC>
	<DOCNO>NCT02447796</DOCNO>
	<brief_summary>The investigator design prospective randomize study compare conventionally use sedative drug propofol late alternative dexmedetomidine ( DEX ) , patient end-stage renal disease undergo arteriovenous fistula ( AVF ) surgery .</brief_summary>
	<brief_title>Dexmedetomidine Propofol As Sole Sedative Agent Patients Undergoing Arteriovenous Fistula Surgery</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>Inclusion criterion patient undergo arteriovenous fistula ( AVF ) surgery age 2070 end stage renal failure dialysis treatment . Exclusion criterion decompensated respiratory heart failure , liver failure , obesity ( body mass index &gt; 30 ) , severe obstructive sleep apnea , need additional different drug sedation , chronic use alcohol , opioids sedative drug , mental disorder , cognitive disorder , language problem history allergy medication use study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>( AVF )</keyword>
	<keyword>surgery</keyword>
</DOC>